Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools
Log in
Sections
You are here: Home Rapid Case Ascertainment

Rapid Case Ascertainment

Leadership

Andrew Olshan, DrPH and Tara Smith Strigo, MPH

Services

Rapid Case Ascertainment (RCA) is an acceleration of the North Carolina Central Cancer Registry's (CCR) reporting process for quick identification of cancer patients throughout the state. Pathology reports are sent from hospitals/facilities within 1 month of diagnosis. The CCR and its ability to provide a RCA system has made N.C. a national leader in population-based cancer research. Without RCA, such research involving timely patient contact is not possible and peer reviewers and agencies may not fund.

Purpose

  • Provide support to the CCR and local hospitals for rapid case ascertainment
  • Facilitate cancer prevention and control research that requires early contact with patients
  • Identify potential cases prior to death or significant morbidity
  • Allow timely interviewing and biologic specimen collection
  • Allow researchers to contact patients who live across the state

The Research Process

  • Researchers contact RCA and the CCR to discuss their upcoming proposal or grant.
  • Individual projects receive IRB approval from their institution(s), and then approval from the CCR.
  • Registrars provide pathology reports, demographics and physician contact information of potentially eligible patients to RCA within 1 month of diagnosis.
  • RCA enters eligible patients’ data in an ACCESS database.
  • RCA mails a brochure outlining the CCR’s role and notification of possible contact by researchers to eligible patients.
  • Data are delivered to the research project. Individual projects will then:
  1. notify physician of intent to contact eligible patient;
  2. mail invitation letter explaining study to eligible patient;
  3. obtain consent;
  4. and continue with their protocol administering in-home / telephone interviews, collecting specimens, etc..

The Rapid Case Ascertainment Core also offers our services to obtain medical records from hospitals, free-standing cancer centers, clinics, physician’s offices, and other treatment facilities for consenting patients participating in approved research projects. Our certified tumor registrar will review and abstract medical record data demographics, history and extent of disease, diagnostic procedures, initial and follow-up treatment, and outcome) and enter it into your study-specific database according to study protocol and time line. We will also retrieve diagnostic tumor blocks or slides from hospitals, free-standing cancer centers, clinics, physician’s offices, pathologists, and other treatment facilities for enrolled subjects, track receipt and processing of blocks in your study-specific database, deliver blocks to the study pathologist/lab for processing, and return all tumor blocks to originating facilities.

Fees

The Core does not charge for its services. Users pay a per-case ascertainment fee ($15) directly to hospitals for pathology reports, as well as monetary support for RCA staff.

Location

Most activities of the Rapid Case Ascertainment staff are based at the N.C. Central Cancer Registry in Raleigh, NC

Hours

8:30 a.m. - 5:00 p.m.

Contact Information

Main Contact: Tara Smith Strigo, 919-972-7472, email An icon indicating that a link will launch an email program.

Staff

Dr. Andrew Olshan, Faculty Director
Tara Smith Strigo, Facility Director
Karen Knight, Director, NCSCHS
Chandrika Rao, Director, CCR

Dianne Kaleel, RCA Coordinator, 919-715-4560 (p), 919-715-1637 (f), email An icon indicating that a link will launch an email program.
Sarah Walden, RCA Coordinator, 919-715-9131 (p), 919-715-1637 (f), email An icon indicating that a link will launch an email program.